Literature DB >> 1201378

Membrane potential changes induced by 5-hydroxytryptamine in the rabbit superior cervical ganglion.

D I Wallis, B Woodward.   

Abstract

1. Changes in resting membrane potential induced by 5-hydroxytryptamine (5-HT) have been measured in the excised ganglion by the sucrose-gap technique. 2. 5-HT produced a rapid depolarization, the threshold concentration for depolarization being around 10 muM. With concentrations of 100 muM or greater, repolarization began during the course of the superfusion; this was followed by prolonged tachyphylaxis. 3. Tachyphylaxis was largely avoided by making injections into the superfusion stream. Standard injections of 0.2 mumol 5-HT dissolved in 0.2 ml of Krebs solution were used routinely and could be given at 20-30 min intervals to evoke relatively constant responses. 4. The response to an injection consisted of a rapid depolarization, followed by a rapid repolarization and subsequent after-hyperpolarization. The threshold quantity for depolarization was around 0.01 mumol, while the ED50 estimated from 6 dose-response curves was 0.12 +/- 0.02 mumol (mean +/- s.e. mean). 5. Injections of 5-HT (0.2 mumol), choline (10 mumol) and acetylcholine (9.9 mumol) produced depolarizations of similar magnitude. 6. Monoamine oxidase inhibitors failed to alter substantially the amplitude of depolarizations to 5-HT. 7. 5-HT depolarizations were unaltered in amplitude when the impermeant anion benzenesulphonate was substituted for the chloride ion in Krebs solution, but were initially markedly reduced in amplitude in a sodium-deficient medium; some recovery of the response subsequently occurred. The depolarization which persisted in sodium-deficient solutions was much reduced or abolished when calcium ions were then removed from the superfusion medium. Removal of either calcium ions alone or potassium ions from the superfusion fluid did not reduce depolarization amplitude. 8. The after-hyperpolarization was abolished in sodium-deficient solutions, usually increased in potassium-free solutions, reduced or abolished by ouabain or nicotine, but unaffected by calcium free solutions. 9. A depolarizing action of 5-HT on presynaptic terminals in the ganglion appears probable.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1201378      PMCID: PMC1666789          DOI: 10.1111/j.1476-5381.1975.tb07629.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  32 in total

1.  Blockade of the ganglionic stimulant action of 5-hydroxytryptamin.

Authors:  L GYERMEK; E BINDLER
Journal:  J Pharmacol Exp Ther       Date:  1962-03       Impact factor: 4.030

2.  A PROBABLE MECHANISM OF ACTION OF SEROTONIN.

Authors:  D W Woolley
Journal:  Proc Natl Acad Sci U S A       Date:  1958-02       Impact factor: 11.205

3.  Recording resting and action potentials by the sucrose-gap method.

Authors:  D I Wallis; G M Lees; H W Kosterlitz
Journal:  Comp Biochem Physiol C       Date:  1975-04-01

4.  The facilitatory actions of 5-hydroxytryptamine and bradykinin in the superior cervical ganglion of the rabbit.

Authors:  D I Wallis; B Woodward
Journal:  Br J Pharmacol       Date:  1974-08       Impact factor: 8.739

5.  The actions of gamma-aminobutyric acid and related amino acids on mammalian autonomic ganglia.

Authors:  W C de Groat
Journal:  J Pharmacol Exp Ther       Date:  1970-04       Impact factor: 4.030

6.  A comparison of the ganglionic stimulating and blocking properties of some nicotinic drugs.

Authors:  J Jaramillo; R L Volle
Journal:  Arch Int Pharmacodyn Ther       Date:  1968-07

7.  Proceedings: The depolarizing action of 5-hydroxytryptamine on sympathetic ganglion cells.

Authors:  D I Wallis; B Woodward
Journal:  Br J Pharmacol       Date:  1973-09       Impact factor: 8.739

8.  Depolarization of isolated rat ganglia by -aminobutyric acid and related compounds.

Authors:  N G Bowery; D A Brown
Journal:  Br J Pharmacol       Date:  1972-05       Impact factor: 8.739

9.  Interaction between picrotoxin and 5-hydroxytryptamine in the superior cervical ganglion of the cat.

Authors:  W C De Groat; P M Lalley
Journal:  Br J Pharmacol       Date:  1973-06       Impact factor: 8.739

10.  Origin of the after-hyperpolarization that follows removal of depolarizing agents from the isolated superior cervical ganglion of the rat.

Authors:  D A Brown; M J Brownstein; C N Scholfield
Journal:  Br J Pharmacol       Date:  1972-04       Impact factor: 8.739

View more
  13 in total

1.  A comparison of fast and slow depolarizations evoked by 5-HT in guinea-pig coeliac ganglion cells in vitro.

Authors:  D I Wallis; N J Dun
Journal:  Br J Pharmacol       Date:  1988-01       Impact factor: 8.739

2.  The properties of 5-HT3 receptors in clonal cell lines studied by patch-clamp techniques.

Authors:  J J Lambert; J A Peters; T G Hales; J Dempster
Journal:  Br J Pharmacol       Date:  1989-05       Impact factor: 8.739

3.  Intracellular recording of the effects of 5-hydroxytryptamine on rabbit superior cervical ganglion cells [proceedings].

Authors:  R A North; D I Wallis
Journal:  Br J Pharmacol       Date:  1977-03       Impact factor: 8.739

4.  Receptors for 5-hydroxytryptamine on the sympathetic nerves of the rabbit heart.

Authors:  J R Fozard; A T Ali
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978 Jan-Feb       Impact factor: 3.000

5.  The depolarizing action of 5-hydroxytryptamine on rabbit isolated preganglionic cervical sympathetic nerves.

Authors:  P Elliott; D I Wallis
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-12       Impact factor: 3.000

6.  Origin of 5-hydroxytryptamine-induced hyperpolarization of the rat superior cervical ganglion and vagus nerve.

Authors:  S J Ireland
Journal:  Br J Pharmacol       Date:  1987-10       Impact factor: 8.739

7.  5-Hydroxytryptamine receptors of visceral primary afferent neurones on rabbit nodose ganglia.

Authors:  H Higashi; S Nishi
Journal:  J Physiol       Date:  1982-02       Impact factor: 5.182

8.  Antagonism of 5-hydroxytryptamine receptors by quipazine.

Authors:  M J Lansdown; H L Nash; P R Preston; D I Wallis; R G Williams
Journal:  Br J Pharmacol       Date:  1980-03       Impact factor: 8.739

9.  5-Hydroxytryptamine-induced bronchoconstriction in the guinea-pig: effect of 5-HT2 receptor activation on acetylcholine release.

Authors:  I Macquin-Mavier; P H Jarreau; N Istin; A Harf
Journal:  Br J Pharmacol       Date:  1991-04       Impact factor: 8.739

10.  The depolarizing action of 5-hydroxytryptamine on rabbit vagal primary afferent and sympathetic neurones and its selective blockade by MDL 72222.

Authors:  J Azami; J R Fozard; A A Round; D I Wallis
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-02       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.